35,752 Followers on Owler

Novo Nordisk

Novo Nordisk is a Danish multinational pharmaceutical company that develops and manufactures insulin and diabetes delivery systems. Read more

Lars Fruergaard Jorgensen's photo - President & CEO of Novo Nordisk

President & CEO

Lars Fruergaard Jorgensen

CEO Approval Rating

68/100

Founded:

1923

Status:

PublicIndependent CompanyNYSENVO

NOVO NORDISK TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Eli Lilly is one of Novo Nordisk's top rivals. Eli Lilly is a Public company that was founded in 1876 in Indianapolis, Indiana. Like Novo Nordisk, Eli Lilly also works within the Pharmaceuticals industry. Compared to Novo Nordisk, Eli Lilly has 7,281 fewer employees.

AstraZeneca is seen as one of Novo Nordisk's biggest rivals. AstraZeneca was founded in 1999 in Cambridge, England. Like Novo Nordisk, AstraZeneca also competes in the Pharmaceuticals sector. AstraZeneca generates $26.6B more revenue than Novo Nordisk.

Biocon is one of Novo Nordisk's top competitors. Biocon was founded in 1978, and its headquarters is in Bangalore, Karnataka. Like Novo Nordisk, Biocon also competes in the Pharmaceuticals space. Biocon has 29,362 fewer employees than Novo Nordisk.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Novartis a competitor of Novo Nordisk?

Novo Nordisk Quarterly and Annual Revenue

Coming soon for Novo Nordisk!

Annual Revenue

$4M

Novo Nordisk's revenue is the ranked 22th among it's top 10 competitors. The top 10 competitors average 26.1B.

Novo Nordisk Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Emisphere Technologies, Inc.

Nov 2020

Source »
$1.8B
Emisphere is a drug delivery company that develops and commercializes oral therapeutics formulations for the pharmaceutical industry.
Corvidia Therapeutics, Inc.

Jun 2020

Source »
$725M
Corvidia is a pharmaceutical firm that develops and commercializes novel therapeutics for the treatment of cardiorenal and chronic kidney disorders.

These are all the companies that Novo Nordisk has acquired. Novo Nordisk has acquired 2 companies and its latest acquisition was Emisphere Technologies, Inc. in Nov 2020. Emisphere is a drug delivery company that develops and commercializes oral therapeutics formulations for the pharmaceutical industry.

Novo Nordisk Funding History

No recent funding data found related to Novo Nordisk

Novo Nordisk Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Glooko is a California-based healthcare platform that provides remote patient monitoring and chronic management solutions for diabetes patients in USA, Germany, and Greece.
$30M
Mar 15, 2021
Series D
-
Xencor focuses on discovery and development of monoclonal antibody therapeutics to treat autoimmune disorders, asthma and allergic diseases.
$15M
Sep 30, 2007
Series E
Dec 02, 2013
Xencor focuses on discovery and development of monoclonal antibody therapeutics to treat autoimmune disorders, asthma and allergic diseases.
$6M
Jul 27, 2006
Unattributed
Dec 02, 2013

These are all the companies that Novo Nordisk has invested in. Novo Nordisk has invested 2 companies and its latest investment was Emisphere Technologies, Inc. in Nov 2020. Emisphere is a drug delivery company that develops and commercializes oral therapeutics formulations for the pharmaceutical industry.

Novo Nordisk News

June 14, 2021Pharmacy Business

LloydsPharmacy and Novo Nordisk team up to launch free nationwide Type 2 diabetes testing in support of Diabetes Week

LloydsPharmacy and Novo Nordisk have joined hands to provide Type 2 diabetes screening services and f... See more »
June 14, 2021Law 360

$1.8B Biotech Sale Targeted In 3 Delaware Class Suits

Attorneys for former Emisphere Technologies Inc. stockholders asked Delaware's Chancery Court to cons... See more »
June 9, 2021The Business Journals: Raleigh/Durham

Clayton facility helps push speedy launch for global pharma's new weight loss drug

The U.S. Food and Drug Administration has approved a weight management drug from a Danish drugmaker w... See more »
June 7, 2021Endpoints News

Novo Nordisk scores a win for semaglutide in obesity, potentially setting up a next-gen battle with Eli Lilly

Novo Nordisk pulled a highly anticipated win for its GLP-1 therapy semaglutide in obesity on Friday, ... See more »
June 7, 2021MarketScreener

Wegovy (semaglutide 2.4 mg), the first and only once-weekly GLP-1 therapy for weight management, approved in the US (Form 6-K)

(marketscreener.com) Wegovy , the first and only once-weekly GLP-1 therapy for weight management, app... See more »
June 7, 2021MarketScreener

Risk of patient overlap between Wegovy and Saxenda obesity drugs, Novo says

(marketscreener.com) Novo Nordisk's new obesity drug Wegovy, far more efficient at causing weight los... See more »
June 7, 2021Outsourcing-Pharma

Novo Nordisk weight-management drug lands FDA approval

The pharmacy company's Wegovy (semaglutide) is the first therapy designated for chronic weight manage... See more »

Novo Nordisk Blogs

Novo Nordisk Press Releases

March 15, 2021centralcharts

Data from STEP clinical trial program evaluating effect of semaglutide 2.4 mg in people with obesity to be presented at 2021 ENDO annual meeting

Data from STEP clinical trial program evaluating effect of semaglutide 2.4 mg in people with obesity ... See more »
February 24, 2021Cision Canada

Novo Nordisk and the University of Toronto announce joint 200 DKK million investment to address diabetes and chronic disease prevention

/CNW/ - Novo Nordisk A/S and the University of Toronto (U of T) today announced a DKK 200 million (CA... See more »
February 12, 2021StreetInsider

Trading in Novo Nordisk shares by board members, executives and associated persons on 11-12 February 2021

Bagsværd, Denmark, 12 February 2021 This document discloses the data of the transaction(s) made in N... See more »
February 5, 2021StreetInsider

Trading in Novo Nordisk shares by board members, executives and associated persons on 3-4 February 2021

Bagsværd, Denmark, 5 February 2021 This company announcement discloses the data of the transaction(s... See more »
January 4, 2021PR Newswire

Novo Nordisk extends COVID-19 Patient Assistance Program, encourages people facing affordability challenges to visit NovoCare.com

PLAINSBORO, N.J., Jan. 4, 2021 /PRNewswire/ -- Today, Novo Nordisk announced the extension of its COV... See more »
December 18, 2020GlobeNewswire

Novo Announces Results of 2020 Annual General Meeting

VANCOUVER, British Columbia, Dec. 18, 2020 (GLOBE NEWSWIRE) -- Novo Resources Corp. ("Novo" or the "C... See more »
November 18, 2020Business Wire

Novo Nordisk Thailand certified as a "Best Place To Work" in 2020

BANGKOK--(BUSINESS WIRE)-- #bestplacestowork--Novo Nordisk Thailand, an affiliate of the global healt... See more »

Novo Nordisk Videos

March 3, 2021Novo Nordisk Youtube Channel

"Obesity: you're not alone" on YOUTUBE

December 18, 2020Novo Nordisk Youtube Channel

"Life-changing careers holiday film" on YOUTUBE

May 13, 2020Novo Nordisk Youtube Channel

"Meet Marie Darting" on YOUTUBE

January 29, 2020Novo Nordisk Youtube Channel

"Meet Christian Luber" on YOUTUBE

Social Media

Novo Nordisk Headquarters

Novo Alle

Bagsvaerd, Capital Region2880

45-4444-8888

Driving Directions »

Trending Companies

Novo Nordisk Summary

ABOUT

Overview

Novo Nordisk is a Danish multinational pharmaceutical company that develops and manufactures insulin and diabetes delivery systems. Novo Nordisk was founded in 1923. Novo Nordisk's headquarters is located in Bagsvaerd, Capital Region, DK 2880. Novo No...

CEO

Novo Nordisk's President & CEO, Lars Fruergaard Jorgensen, currently has an approval rating of 68%. Novo Nordisk's primary competitors are Eli Lilly, AstraZeneca & Biocon.

Frequently Asked Questions about Novo Nordisk

  1. When was Novo Nordisk founded?

    Novo Nordisk was founded in 1923
  2. Who is Novo Nordisk's CEO?

    Novo Nordisk's CEO is Lars Fruergaard Jorgensen
  3. How much revenue does Novo Nordisk generate?

    Novo Nordisk generates $4M in revenue
  4. How much funding does Novo Nordisk have?

    Novo Nordisk has historically raised $0 in funding
  5. Where is Novo Nordisk's headquarters?

    Novo Nordisk's headquarters is in Bagsvaerd Capital Region, DK
  1. How many employees does Novo Nordisk have?

    Novo Nordisk has 41,971 employees
  2. What sector does Novo Nordisk operate in?

    Novo Nordisk is in Pharmaceuticals
  3. Who are Novo Nordisk's competitors?

    Novo Nordisk's top competitors are Eli Lilly, AstraZeneca, Biocon
  4. Who has Novo Nordisk invested in?

    Novo Nordisk's has invested in companies such as Glooko, Xencor, Xencor